Mainstay
-
Neuro
Mainstay Medical ReActiv8-A sustains performance at one year in clinical trial
27th September 2016 Mainstay Medical has announced the one-year results from the ReActiv8-A Clinical Trial, an international, multi-centre, prospective, single…
Read More » -
Hospitals
Mainstay Medical Achieves CE Marking for ReActiv8® and Prepares for Commercial Launch in Germany
May 25, 2016 – DUBLIN–(BUSINESS WIRE)–Regulatory News: Mainstay Medical International plc (Euronext Paris: MSTY.PA and ESM of the Irish Stock Exchange:…
Read More » -
Hospitals
Mainstay Medical Gains Approval to Start US Clinical Trial of ReActiv8®
Dublin – Ireland, 29th May 2015 – Mainstay Medical International plc (“Mainstay” or the “Company” listed on Euronext Paris: MSTY.PA…
Read More »